Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Lisata Therapeutics Dividend Announcement
• Lisata Therapeutics announced a annually dividend of $0.00 per ordinary share which will be made payable on . Ex dividend date: 2013-10-28
• Lisata Therapeutics's trailing twelve-month (TTM) dividend yield is -%
Lisata Therapeutics Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2013-10-28 | $0.00 | annually | |
2011-04-04 | $0.00 | annually |
Lisata Therapeutics Dividend per year
Lisata Therapeutics Dividend Yield
Lisata Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lisata Therapeutics stock? Use our calculator to estimate your expected dividend yield:
Lisata Therapeutics Financial Ratios
Lisata Therapeutics Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Lisata Therapeutics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.